Morningstar

Advanced Medical Solutions Group PLC AMS

Morningstar Rating
Unlock
Stock XLON Rating as of
GBX 212.00 −3.00 (1.40%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Advanced Medical Solutions Makes Progress on Its Branded Portfolio

Debbie S. Wang

Originally an original equipment manufacturer for advanced wound-care products, Advanced Medical Solutions has built on its technical expertise and expanded into adjacent markets. Though AMS remains significantly smaller than Smith & Nephew, Molnlycke, and ConvaTec, we like how it has shifted its focus toward higher-margin branded surgical products and believe this strategy should enhance its already attractive returns on invested capital.

Read Full Report

Price vs Fair Value

View History
AMS is trading at a 429% premium.
Price
GBX 212.00
Fair Value
GBX 932.00
Uncertainty
Medium
1-Star Price
GBX 116.90
5-Star Price
GBX 821.20
Economic Moat
Gjxpk
Capital Allocation
Dqfdtkxlp

Bulls Say, Bears Say

Bulls

We think AMS' intellectual property, trade secrets, materials, and manufacturing expertise make it difficult to simply copy its products.

Bears

With branded wound care manufacturers racing to build out their biologic and tissue-based therapies, AMS could have a hard time penetrating this niche, as it requires a different expertise than what is needed for more common wound care products, such as foams and silvers.

Show More

Trading Information

Previous Close Price
GBX 215.00
Day Range
GBX 210.50–217.00
52-Week Range
GBX 171.60–275.83
Bid/Ask
GBX 0.00 / GBX 0.00
Market Cap
GBX 45.47 Bil
Volume/Avg
250,262 / 408,068

Key Statistics

Price/Earnings (Normalized)
19.42
Price/Sales
3.53
Dividend Yield (Trailing)
1.15%
Dividend Yield (Forward)
1.15%
Total Yield
2.63%

Company Profile

UK-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
1,500
Website
https://www.admedsol.com

Competitors

Valuation

View More
Metric
AMS
JNJ
COLO B
Price/Earnings (Normalized)
 19.4215.3839.36
Price/Book Value
 2.045.4211.93
Price/Sales
 3.534.587.48
Price/Cash Flow
 22.7317.3957.32
Price/Earnings
AMS
JNJ
COLO B

Financial Strength

Metric
AMS
JNJ
COLO B
Quick Ratio
 6.800.770.53
Current Ratio
 8.391.070.85
Interest Coverage
 —24.458.81
Quick Ratio
AMS
JNJ
COLO B

Profitability

Metric
AMS
JNJ
COLO B
Return on Assets (Normalized)
 6.74%13.17%11.10%
Return on Equity (Normalized)
 9.40%32.42%35.43%
Return on Invested Capital (Normalized)
 6.97%20.93%15.15%
Return on Assets
AMS
JNJ
COLO B

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
YbqhcckdpPbv$172.9 Bil
 Becton Dickinson & Co
BDX
VgrdwlndzWsqjxdy$69.3 Bil
 Alcon Inc
ALC
XrvckffzPygnp$49.2 Bil
 ResMed Inc
RMD
HrnghmvkhPmtym$35.1 Bil
 Coloplast AS ADR
CLPBY
HrjsrdwwpwJzls$29.2 Bil
 West Pharmaceutical Services Inc
WST
WwcbnjxkNzpy$21.7 Bil
 The Cooper Companies Inc
COO
YmtlbjhDjtfvr$21.5 Bil
 Hologic Inc
HOLX
SsrdgbqqxFgjgzzx$18.5 Bil
 Baxter International Inc
BAX
SgccxmsvTkhwcq$18.4 Bil
 Align Technology Inc
ALGN
SwmctdyFlptpy$17.8 Bil

Sponsor Center